Galmed Pharmaceuticals Ltd.

NasdaqCM:GLMD Stock Report

Market Cap: US$4.2m

Galmed Pharmaceuticals Ltd. Company Information

Galmed Pharmaceuticals Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: Galmed Pharmaceuticals Ltd.
  • Ticker: GLMD
  • Exchange: NasdaqCM
  • Founded: 2000
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$4.220m
  • Shares Outstanding: 1.51m
  • Website: https://www.galmedpharma.com

Number of Employees

Location

  • Galmed Pharmaceuticals Ltd.
  • 16 Abba Hillel Road
  • Ramat Gan
  • 5250608
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GLMDNasdaqCM (Nasdaq Capital Market)YesNew Ordinary SharesUSUSDMar 2014
GPHDB (Deutsche Boerse AG)YesNew Ordinary SharesDEEURMar 2014

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 19:09
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.